Experimental Study of Antispasmodic Activity of  2-Oksoindolin-3-Glyoxylic Acid Derivatives by Lutsenko, R. et al.
Journal of Materials Science and Engineering B 4 (6) (2014) 
Experimental Study of Antispasmodic Activity of 
2-Oksoindolin-3-Glyoxylic Acid Derivatives  
Lutsenko R.V. and Sydorenko A.H.  
Higher State Educational Establishment of Ukraine, Ukrainian Medical Dental Academy, Poltava 
 
Received: December 16, 2014 / Accepted: January 11, 2014 / Published: June 25, 2014. 
 
Abstract: Clinical psychiatry and neurology requires a creation of new means with difficult many component range of psychotropic 
action, so psychoemotional disturbances “boundary type” and difficult mental disorders have high level of heterogeneity, various 
clinical manifestations, which are caused by different pathogenetic factors. One of the most often used preparation for the treatment of 
these diseases is anxiolytic medications. It is known that anxiolytic action combines with anticonvulsive. Perspective medications are 
simple amides and ethers of 2-oksoindolin-3-glyoxylic acid, which have not recognized and practically observed. The aim of this 
research is to determine anticonvulsant action in 2-oksoindolin-3-glyoxylic acid derivatives on the model of acute myoclonic 
pentylentetrazol, piktrotoxic, and bikukullin convulsions. In experiments on mature mice of both sex Wistar line were studied an 
influence of ethyl ester 4-[2-hydroxy-2-(2-oxo-1,2-dihydro-indol-3-ylidene)-acetylamino]-butyric acid and 
2-hydroxy-N-naphthalen-1-yl-2-(2-oxo-1,2-dihydro-indol-3-ylidene)-acetamide on chemoinduced epileptogenesis. An intake of 
proconvulsants is accompanied by a development of syndrome convulsion, which was estimated by convulsion’s intensity (grades), 
latent period of convulsions (sec.), number of convulsions acts, and duration of convulsions (sec.) and number of survived animals in a 
group. It was showed that a combination of 2-hydroxy-N-naphthalen-1-yl-2-(2-oxo-1,2-dihydro-indol-3-ylidene)-acetamide (12 
acetamide mg/kg) is similar to reference preparation diazepam in (2 mg/kg) which decreased a manifestation of syndrome convulsion. It 
demonstrated an increase of intensity of convulsions, decrease of latent period of the convulsion’s start which is caused by all blockers 
GАМКА-receptors, decrease of number convulsive acts on the background of korazol and pikrotoxin, a decrease of convulsive syndrome 
duration during an intake of korazol and bikukullin, and a decrease of animal’s mortality, which was caused by pikrotoxin intake.  
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1. Introduction

 
Dangerous disturbances contain medical, social and 
economical problem which is used among different 
disorders of mental activity [1]. In countries of 
Eurounion, the spread of dangerous disturbances 
contain about 15% in all population [2]. Necessity of 
neurotic pathology is approved by peculiarities, for 
which chronic duration is characterized. Left untreated, 
this pathology passes into chronic one, it is often 
progressed that can lead to small percent of cure. [3]. 
Dangerous disturbances are caused by social and 
                                                         
  Corresponding author: 
 
 
professional disadaptation to disability and reduction 
of life’s quality. The third parts of costs are caused by 
mental disorders and can be a part of psychiatric 
diseases [4]. Mental disorders are caused by depressive 
symptomatology, considerably complicate prognosis 
and lead to suicide and difficult somatic pathology [5]. 
The most frequently anxiolytic means, according to 
mental disorders, it is prescribed only at subclinical and 
completed psychopathological conditions. Means for 
correction of mental functions, besides psychiatry are 
widely used by specialists of different fields of 
medicine and are a part of therapy’s standards by many 
somatic diseases [6]. 
The usage of traditional anxiolytic preparations can 
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be difficult because of development of side effects and 
possible complications which are serious and 
connected with high addictive potential, especially it 
concerns with benzidiasapazapine derivatives. At 
prescription of atypical tranquilizators wanted effect 
can be not at once, it requires an individual sensitivity 
to the preparation which is estimated very difficult.  
Perspective investigations are research in the field of 
pharmacological properties of new chemical 
combinations especially of 2-oksoindolin-3-glyoxylic 
acid derivatives. Indole derivatives have such 
properties of natural inhibitors monoamine oxidase and 
due to structural similarity they are capable in CNS 
interrelate with serotonin α-adrenoreceptors and 
dofamine receptors [7]. Indole alkaloids can 
interrelate with μ-opiod receptors, GABAА-receptors, 
NMDA-receptors, conversingly inhibit into 
acetylcholinesterase [8].  
2-oksoindolin-3-glyoxylic acid derivatives have 
antihypoxic, antianxiolytic, stressprotective activity, 
and ability of modification behavior reactions and have 
an influence on emotional sphere among animals. In 
the basis of such effects there is neurotropic activity.  
That’s why it is necessary to identify a presence in 
more perspective combinations anticonvulsant activity, 
which is often accompanied by antianxiolytic one. The 
aim of the research is to determine anticonvulsant 
activity in 2-oksoindolin-3- glyoxylic acid derivatives 
on the model of acute myoclonic pentylentetrazol, 
piktrotoxic, and bikukullinic convulsions.  
2. Materials and Methods  
Experiments were held on mature mice of both sex 
of Wistar line, groups of animals were (n=10) 
randomized according to the sex and age. Mice were in 
vivarium at natural light and standard alimentary ration 
into plastic cages. There were five mice in every cage. 
All investigations were provided with observations of 
bioethical requirements and recommendations of 
European convention of vertebrate’s defense, which 
are used in experimental and other research purposes. 
Experimental investigation was performed in spring 
time at 9 o’clock and one looked parallel for animals 
with eaсh group individually. Investigations were 
provided in similar conditions, in isolated building 
beyond out of external noise.  
2-Oksoindolin derivatives these substances of ethyl 
ether 4-[2-hydroxy-2-(2-oxo-1,2-dihydro-indol-3- 
ylidene)-acetylamino]-butyric acid (connection E-38) 
and 2-hydroxy-N-naphthalen-1-yl-2-(2-oxo-1,2- 
dihydro-indol-3-ylidene)-acetamide (connection 18) ex 
tempore were suspended in water for injections to use 
an emulsifier “Tvin -80” (1 drop and 10 mg of 
substance) and were administered into animals 
intraperitoneally in toxic dosage (4,3 mg/kg and 12 
mg/kg) about diazepam for 1 hour to intake GABA, 
ergic ligands. It was used korazol (Sigma-Aldrich, 
USA) in the dosage of 80 mg/kg of human’s weight, 
blocker Cl
-
 of chloric channel of GABAА-receptor of 
complex, piktrotoxin (Sigma-Aldrich, USA) in the 
dosage of 5 mg/kg of human’s weight is a model 
antagonist GABAА-receptors which blocks activated 
GABA of tokion’s chlorine through a receptor and 
bikukullin (Sigma-Aldrich, USA) in the dosage of 5 
mg/kg, is classical allosteric inhibitor of low-affinity 
GABAА-receptors. Analyzers of synaptic transmission 
were administered subcutaneously in the area of 
cervical region of back. In experiments diazepam was 
used (“Tarchomin S.A.”, Poland), it is an agonist 
benzodiazepine receptors which increases frequency of 
opening chloric channel of GABAА-receptor in the 
dosage of 2 mg/kg of human’s weight.  
An intake of pikrotoxin, korazol and bikukullin is 
followed by a development of convulsing syndrome, 
which was estimated according indexes: latent period 
of convulsions (sec.), number of convulsion’s acts, 
duration of convulsions (sec.) and number of survived 
animals in group. Also it was studied an intensity of 
convulsion attack development due to 6-grade scale 
[9]: 0 is an absence of convulsion’s activity; 1 is 
hyperkinesia; 2 is shake, twitch; excessive grooming, 
stereotypic movements; 3 is clonic convulsions of the 
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front paws with rise on the back ones; 4 is expression 
of tonic and clonic convulsions, falling down on the 
flank, a presence of phase of tonic extension; 5 are 
repetitive clonic and tonic convulsions, loss of pose, 6 
is complete tonic attack with apnea, animal’s death. It 
has been estimated an ability to depress clonic and 
tonic convulsions, to increase latent period, to decrease 
number, to reduce general duration of convulsive 
syndrome and mortality of animals. 
Statistic analyses of investigation was provided due 
to such programmes: Statistica 6.0 (StatSoft, Inc., 
USA) and use of dispersive analysis ANOVA and 
criteria χ
2
 [10]. A comparison of received results was 
performed using t-criteria Styudent, changes were 
estimated right at p ≤ 0.05. 
3. Results and their Discussion 
An influence of 2-oksoindolin-3-glyoxylic acid 
derivatives on GABA, ionofor-receptor complex was 
estimated on the model of korazol, pikrotoxic and 
bikukullin experimental convulsive syndrome to its 
ability to modify clinical picture of intoxication.  
The first stage of experiments showed that 
korazol’s intake in the dosage of 80 mg/kg caused a 
development of convulsive syndrome. A mortality of 
animals contained 50% (Table 1).  
During intensity of convulsive attack after korazol 
intake it was indicated, convulsions increased in 1,5 
times in comparison with convulsant’s intake without 
pharmocoprevention (p < 0.001) (Fig. 1). Also 
reference-preparation increased time of latent of 
convulsion’s development and increased a number of 
convulsive acts in 1,8 times in comparison with control 
pathology (p < 0.001) (Table 1). Prophylactic diazepam 
intake increased a duration of convulsive period in 
animals in 2 times and mainly reduced animal’s 
mortality in comparison with GABAА-blocker without 
correction (p < 0.001) (Table 1). 
In the result of given investigations it was indicated 
that preventive intake of 2-oksoindolin-3-glyoxylic 
acid derivatives E-38 cannot cause statistic changes of 
none of indexes of convulsion’ s development 
syndrome and causes anticonvulsive action at 
convulsions which are caused by korazol’s intake. 
Preventive usage of a substance with lab cipher 18 is 
analogically to reference-preparation reduced intensity 
of korazol’s convulsive syndrome in animals in 1,7 
times in comparison with control pathology (p < 0.001) 
(Fig. 1). An intake of combination 18 increased a 
duration of latent period from the beginning of 
convulsions in 1,9 times in comparison with control 
pathology (p < 0.001). At this time number of 
convulsive acts reduced in animals. (Table 1). After 
reproduction of chemo-induced korazol of 
epileptogenesis, substance 18 decreased a duration of 
convulsive period in animals in 2,3 times in 
comparison with animals without intake of 
2-oksoindolin derivative (p < 0.001). Also in this 
experimental group it is not observed mortality after 
convulsant’s intake (Table 1). 
During the second stage of experiments, a 
development of convulsive pathology in experimental 
animals were modeled by intake of pikrotoxin in the 
dosage of 5 mg/kg. After pikrotoxin’s intake, as a 
model antagonist of GABAА-receptors in animals 
developed classical convulsive syndrome, which  
 
Table 1 An influence of 2-oksoindolin-3-glyoxylic acid derivatives and diazepam on convulsions which was caused by 
korazol intake (80 mg/kg), M ± m.  
Group of animals  
n = 10 
Latent period of 
convulsions, sec. 
Number of convulsive 
acts, sec. 
Duration of 
convulsions, sec. 
Animal’s mortality in 
a group  
1. Control pathology  312.5 ± 26.8 10.6 + 0.84 2800 ± 296 10/5 
2. Diazepam, 2 mg/kg 
Р 1-2 
417.5 ± 29.3 
< 0.02 
5.9 + 0.43 
< 0.001 
1409 ± 123 
< 0.001 
10/1 
> 0.25(χ2) 
4. Substance E-38 
Р 1-3 
374.7 + 32.9 
> 0.25 
10.1 + 0.84 
> 0.25 
1437 + 174 
< 0.001 
10/5 
> 0.25(χ2) 
5. Substance 18 
Р 1-4 
603.2 + 30.9 
< 0.001 
5.1 + 0.54 
< 0.001 
1208 + 60 
< 0.001 
10/1 
> 0.25(χ2) 
 
 
Experimental Study of Antispasmodic Activity of 2-Oksoindolin-3-Glyoxylic Acid Derivatives 
  
4 
 
 
Fig. 1  An influence of 2-oksoindolin-3-glyoxylic acid 
derivatives and diazepam on convulsion’s intensity at 
korazol’s intake (80 mg/kg). *Р ≤ 0.05. 
(1) Control pathology; (2) Diazepam, 2 mg/kg; (3) Substance 
E-38; (4) Substance 18. 
 
showed 100% of animal’s mortality (Table 2). 
Under influence of diazepam convulsive syndrome 
modified significantly which was caused by 
pikrotoxin. There was a decrease of convulsions in 
animals in 1.4 times in comparison with convulsant’s 
intake without pharmacoprevention (p < 0.001) (Fig. 
2). Also preventive usage of diazepam increased latent 
period of convulsion’s start in 2.4 times (p < 0.001) 
and decreased a number of convulsions in 1.7 times (p 
< 0.002) in comparison with control pathology. An 
intake of classical tranquilizer diazepam on the 
background of pikrotoxin prevented a mortality of 
animals (Table 2).  
At analysis of anticonvulsive action of 
2-oksoindolin derivatives it is important to note 
substance E-38 did not influence on studied 
parameters of convulsive pikrotoxin syndrome.  
On the background of pikrotoxin’s intake 
combination 18, analogically to preparation of 
comparison diazepam, decreased a severity of 
convulsive syndrome in experimental animals 
effectively and veraciously (Fig. 2). 2-oksoindolin 
derivatives with lab cipher 18 prolonged a latent period 
of the beginning of convulsions in 2 times in 
comparison with convulsant’s intake without 
correction (p < 0.001). Also preventive substance’s 
intake 18 decreased a number of convulsions in 1.9 
times (p < 0.001). In animals a duration of convulsive 
period decreased and it was not registered lethal issues 
in comparison with control pathology (Table 2). 
During next stage of experiments it was studied an 
influence of 2-oksoindolin-3-glyoxylic acid derivatives 
on convulsive action of bikukullin. An inhibitor’s 
intake of low-affinity of GABAА-receptors caused a 
development of convulsive syndrome in animals, 
which was over lethally in half cases.  
Diazepam’s intake before convulsant’s use 
decreased an intensity of convulsive syndrome in 
comparison with control pathology (Fig. 3). Diazepam 
prolonged at period of convulsion’s start in 1,3 times in 
comparison with control pathology (p < 0.001) (Table 
3). Also preparation of comparison decreased a 
number and duration of convulsive acts. 
Preventive of an intake of E-38 combination did not 
have an influence on intensity, latent period, number 
and duration of convulsive acts on the background of 
bikukullin’s intake. At that time a substance with lab 
cipher 18 decreased a manifestation of convulsive 
syndrome. Protective action of 2-oksoindolin 
derivative demonstrated an increase of latent period of 
the convulsion’s start in 1.2 times in comparison with 
control pathology (p < 0.01). At that time combination 
18 decreased a duration of convulsive syndrome in 
comparison with bikukullin’s intake without 
pharmocorrection  (Table 3).  Received  results  of  this 
 
Table 2 An influence of 2-oksoindolin-3-glyoxylic acid derivatives and diazepam on convulsions which was caused by 
pikrotoxin’s intake (5 mg/kg), M ± m 
Group of animals 
n = 10 
Latent period of 
convulsions, sec. 
Number of convulsive 
acts, sec. 
Duration of 
convulsions, sec. 
Animal’s mortality in 
a group 
1. Control pathology  510.4 ± 35.7 12.1 ± 1.10 1,975 ± 115 10/10 
2.Diazepam, 2 mg/kg 
Р 1-2 
1,200 ± 50.7 
< 0.001 
7.33 ± 0.62 
< 0.002 
1,719 ± 162 
> 0.25 
10/0 
< 0.001 (χ2) 
3.Substance E-38 
Р 1-3 
541.6 ± 37.5 
> 0.25 
12.8 ± 1.2 
> 0.25 
1,984 ± 85.4 
> 0.25 
10/9 
> 0.25(χ2) 
4. Substance 18 
Р 1-4 
1,009 ± 41.4 
< 0.001 
6.4 ± 0.52 
< 0.001 
1,674 ± 95.0 
< 0.1 
10/0 
< 0.001(χ2) 
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Table 3 An influence of 2-oksoindolin-3-glyoxylic acid derivatives and diazepam on convulsion’s intake of bikukullin (5 
mg/kg), M ± m.  
Group of animals 
n = 10 
Latent period of 
convulsions, sec. 
Number of convulsive 
acts, sec. 
Duration of 
convulsions, sec. 
Animal’s mortality in 
a group 
1. Control pathology 165.4 ± 6.78 9.3 ± 0.84 2,328.4 ± 105 10/5 
2.Diazepam, 2 mg/kg 
Р 1-2 
214.9 ± 10.0 
< 0.001 
6.1 ± 0.45 
< 0.01 
1,785 ± 116 
< 0.01 
10/2 
> 0.25(χ2) 
3. Substance E-38 
Р 1-3 
181.1 ± 9.48 
> 0.25 
8.8 ± 0.83 
> 0.25 
2,385 ± 123 
> 0.25 
10/6 
> 0.25(χ2) 
4. Substance 18 
Р 1-4 
198.9 ± 7.08 
< 0.01 
8.3 ± 0.82 
> 0.25 
1,975 ± 102 
< 0.05 
10/4 
> 0.25(χ2) 
 
 
Fig. 2  An influence of 2-oksoindolin-3-glyoxylic acid 
derivatives and diazepam on convulsion’s intensity which 
was caused by pikrotoxin’s intake (5 mg/kg). *Р≤0,05.  
(1) Control pathology; (2) Diazepam, 2 mg/kg; (3) Substance 
E-38; (4) Substance 18. 
 
 
Fig. 3  An influence of 2-oksoindolin-3-glyoxylic acid 
derivatives and diazepam on convulsion’s intake of 
bikukullin (5 mg/kg). 
(1) Control pathology; (2) Diazepam, 2 mg/kg; (3) Substance 
E-38; (4) Substance 18. 
 
stage of animals testify that 2-oksoindolin-3-glyoxylic 
acid derivative (substance 18) decreased a 
manifestation of convulsive bikukullin’s activity in 
the extension of convulsion’s start and increased a 
duration of convulsions. 
In the result of performed experiments it was 
indicated a combination E-38 does not have an 
influence on a severity of convulsive syndrome at 
korazol’s, pikrotoxin’s, bikukullin’s intake. It allows 
suggesting an absence of interrelation of this 
substance with subunits of GABAА-receptor complex 
.  
Preventive intake of 2-oksoindolin derivative, 
substance with lab cipher 18, modified greatly a 
clinical picture of intoxication which was caused by 
korazol’s pikrotoxin’s, bikukullin’s intake, that 
demonstrated a decrease of intensity of convulsive 
syndrome, an increase of latent period of convulsions, 
reduction of number and duration of convulsions, in 
prevention animal’s mortality. So, efficacy of 
anticonvulsive action of substance 18 at 
pharmacological chemo-induced epileptogenesis is a 
predictor its effectiveness at convulsive pathology in 
patients at clinic, especially at absence seizures and 
reduced forms of epilepsy.  
Proconvulsive action of pikrotoxin and korazol is 
connected with inhibition of GABAА-receptors on the 
blocker’s level chloric currents through ionofor [11]. 
Considering that a presence of specific site of receptor 
convulsive action of korazol is closely connected with 
blocker and changes in the structure of 
GABAА-receptors [12]. Received data allow 
suggesting, a decrease of convulsive syndrome under 
an influence of 2-oksoindolin derivative is determined 
by definite modulation and condition of 
GABAА-receptors, which caused convulsive agents.  
Also anticonvulsive action of 2-oksoindolin 
derivative has competitive and simulated allosteric 
interrelations, which are determined by 
conformational changes in area of ionofor of 
GABAА-receptor. Such hypothesis can be considered, 
whereas combination 18 was inserted in prophylactic 
way, and it is able to cause changes in sites of 
convulsants, that caused following decrease of ability 
of GABAА-blockers. However such interrelation 
should not studied as direct opposition and 
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displacement of convulsants in sites of their 
combination.  
Other possible mechanism of anticonvulsive action 
of 2-oksoindolin derivative can be determined by 
ability to modify and influence on serotonin in CNS, 
which has been showed by us in previous 
investigations. Present hypothesis is approved by 
interrelation between GABA-ergic and serotonin and 
ergic systems on the level of pyramidal cells of brain 
[13], and also ability of agonists of serotonin 1А, 
receptors modify experimental convulsive syndrome 
[14] as it was showed for other indole derivatives. It 
should be noted a release of serotonin in neuronal 
network of brain is regulated by brake GABA-ergic 
interneurons [15]. Blockage of GABAА-receptors of 
proconvulsants causes a decrease of brake influence on 
serotonin’s output, that leads to an increase of 
serotonin’s output.  
4. Conclusions  
In the result of performed investigations it was 
indicated, at preventive intake of 
2-oksoindolin-3-glyoxilic acid derivatives combination 
2-hydroxy-N-naphthalen-1-yl-2-(2-oxo-1,2-dihydro-in
dol-3-ylidene)-acetamide in the dosage 12 mg/kg 
effectively decreased a manifestation of convulsive 
syndrome. It demonstrated a decrease intensity of 
convulsive syndrome, increase of latent period of 
convulsion’s start, which was caused by korazol’s, 
pikrotoxin’s, bikukullin’s intake, decrease of number of 
convulsive acts on the background of korazol and 
pikrotoxin, decrease of duration of convulsive syndrome 
during korazol’s and bikukullin’s intake, and also 
decrease of animal’s mortality which was caused by 
pikrotoxin’s intake. Received results show a presence of 
2-oksoindolin derivative anticonvulsive activity in 
mechanisms that plays direct or indirect role of 
GABA-ergic system.  
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